Cardiovascular effects of secretin infusion in man.
暂无分享,去创建一个
[1] K. Rasmussen,et al. Cardiovascular effects of glucagon. , 2009, Acta medica Scandinavica.
[2] A. Berstad,et al. The diuretic effect of secretin in man. , 1980, Scandinavian journal of clinical and laboratory investigation.
[3] H. Waldum,et al. The effect of secretin on renal haemodynamics in man. , 1980, Scandinavian journal of clinical and laboratory investigation.
[4] Burhol Pg,et al. Radioimmunoassay of secretin in acidified plasma. , 1978 .
[5] B. Hoel. Some aspects of the clinical use of thermodilution in measuring cardiac output. With particular reference to the Swan-Ganz thermodilution catheters. , 1978, Scandinavian journal of clinical and laboratory investigation.
[6] G. Diamond,et al. Thermodilution cardiac output determination with a single flow-directed catheter. , 1972, American heart journal.
[7] H. Swan,et al. Measurement of blood flow by thermodilution. , 1972, The American journal of cardiology.
[8] W. Parmley,et al. Glucagon: a new agent in cardiac therapy. , 1971, The American journal of cardiology.
[9] G. Ross. Cardiovascular effects of secretin. , 1970, The American journal of physiology.
[10] J. Fahrenkrug,et al. Pancreatic response and plasma secretin concentration during infusion of low dose secretin in man. , 1978, Scandinavian journal of gastroenterology.
[11] J. Mcguigan,et al. Radioimmunoassay measurement of secretin half-life in man. , 1977, Gastroenterology.